Terray Therapeutics integrates ultra-high throughput experimentation with generative AI, biology, medicinal chemistry, automation, and nanotechnology to transform small molecule drug discovery.

Orasis Pharmaceuticals develops and commercializes corrective eye drops for treating presbyopia in adults.

Thintronics Inc. develops high-performance insulator materials for AI datacenters, networking, and RF/mmW applications to enhance electrical and mechanical properties.

Spear Bio Inc. is a biotech firm specializing in ultrasensitive immunodiagnostics and proteomics, offering advanced sensitivity in digital immunoassays and focusing on biomarker discovery and early chronic disease diagnosis.